<p><b>TABLE OF INTERACTIONS WITH</b></p>

<p><b>ANTIPARASITICS THAT TEND TO INDUCE TORSADES DE POINTES</b></p>

<p><b>From the French ANSM drug interactions document of September 2016, p. 27</b></p>

<table cellspacing="0" cellpadding="0" border="1">
<tbody>
<tr>
<td valign="top"><p><b>ANTIPARASITICS THAT TEND TO INDUCE TORSADES DE POINTES</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>P01B-001</b></p></td>
<td valign="top"><p><b>SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C01-N05</b></p></td>
<td valign="top"><p>Increased risk of ventricular arrhythmias, especially of torsades de pointes</p></td>
<td valign="top"><p><b>Contraindication</b></p>

<p>with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine</p>

<p><b>Not recommended</b></p>

<p>with the other medications that tend to induce torsades de pointes</p>

<p>If this is possible, interrupt one of the two treatments. If administering the substances together cannot be avoided, testing of the QT before treatment and EKG monitoring</p></td>
</tr>

</tbody>
</table>

